Stocks and InvestingStocks and Investing
Wed, August 18, 2021
Tue, August 17, 2021
Mon, August 16, 2021
Sun, August 15, 2021
Fri, August 13, 2021

Gregory Renza Maintained (APRE) at Hold with Decreased Target to $100 on, Aug 13th, 2021


Published on 2024-10-27 17:39:08 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Maintained "Aprea Therapeutics, Inc." (APRE) at Hold with Decreased Target from $120 to $100 on, Aug 13th, 2021.

Gregory, nor any peers, have made any analyst calls on APRE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30